跳至主要内容
临床试验/CTRI/2019/02/017776
CTRI/2019/02/017776尚未招募1 期

â??To Evaluate the Safety and Tolerability of HCLX 031706 in Healthy Adult Volunteers: Randomized, Open Label, Two Arm, Clinical Studyâ??

The Himalaya Drug Company Ltd0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
1 期
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Young Healthy Adolescent male and female subjects.
  • Aged between >=18 years to <= 25 years.
  • Subjects who can refrain or who are not on any other supplements for constipation
  • Subjects willing to sign informed consent and follow the study procedure.
  • Has not participated in any clinical study in the last one month.

排除标准

  • Subjects with any clinical significant systemic illness.
  • A known history or present condition of allergic response to products its components or to any of the ingredients in the test product
  • Pre-existing systemic disease requiring long-term medications.
  • Subjects treated with any laxatives 2 weeks prior to screening and are experiencing the laxative effect.
  • Pregnant & nursing women.

研究者

相似试验